Skip to main content
SpringerLink
Log in

Biopharmaceutics and Veterinary Drug Delivery

  • Chapter
  • First Online:
Long Acting Animal Health Drug Products

Part of the book series: Advances in Delivery Science and Technology ((ADST))

  • 1598 Accesses

Abstract

Biopharmaceutics operates at the interface of pharmaceutics and physi­ology. This chapter discusses observations and studies that emphasize the similarities and differences in species and routes of administration while providing references for notable reviews. The quintessential requirement of drug dissolution is discussed for immediate release formulations, and the use of biodegradable microspheres is reviewed for controlled release injectable formulations. From nasal and ocular to transdermal and oral, examples of formulations for veterinary practice are presented. If the formulation and the biopharmaceutics results in a well-absorbed drug product in one species, would it will behave similarly in other species? We can predict this when we have a sound understanding of the sometimes specie-specific physiology, and pharmaceutical knowledge of the formulation. With numerous routes of administration and preclinical studies already public knowledge, we may be on the brink of the golden age of veterinary pharmaceuticals.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    8th edition. © 2009, Elsevier

  2. 2.

    http://medical-dictionary.thefreedictionary.com/biopharmaceutics

References

  1. Gilor C, Graves TK (2010) Synthetic insulin analogs and their use in dogs and cats. Vet Clin North Am Small Anim Pract 40:297–307

    Article  PubMed  Google Scholar 

  2. Shah J, Sutton S, Way S, Brazeau G (2012) Parenteral formulations: local injection site reaction and muscle tolerance. In: Swarbrick J (ed) Encyclopedia of pharmaceutical technology. Informa Healthcare USA, Inc, New York

    Google Scholar 

  3. Sutton SC, Engle K, Fix JA (1993) Intranasal delivery of the bisphosphonate alendronate in the rat and dog. Pharm Res 10:924–926

    Article  CAS  PubMed  Google Scholar 

  4. Robertson SA, Taylor PM, Sear JW, Keuhnel G (2005) Relationship between plasma concentrations and analgesia after intravenous fentanyl and disposition after other routes of administration in cats. J Vet Pharmacol Ther 28:87–93

    Article  CAS  PubMed  Google Scholar 

  5. Harai S, Ikenaga T, Matsuzawa T (1978) Nasal absorption of insulin in dogs. Diabetes 27:296–299

    Article  CAS  PubMed  Google Scholar 

  6. Proksch JW, Granvil CP, Rl Siou-Mermet TL, Comstock MRP, Ward KW (2009) Ocular pharmacokinetics of besifloxacin following topical administration to rabbits, monkeys, and humans. J Ocul Pharmacol Ther 25:335–344

    Article  CAS  PubMed  Google Scholar 

  7. Gaudana R, Ananthula H, Parenky A, Mitra A (2010) Ocular drug delivery. AAPS J 12:348–360

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Derendorf H, Mollmann H, Gruner A, Haack D, Gyselby G (1986) Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration. Clin Pharm Ther 39:313–317

    Article  CAS  Google Scholar 

  9. Ratcliffe JH, Hunneyball IM, Smith A, Wilson CG, Davis SS (1984) Preparation and evaluation of biodegradable polymeric systems for the intra-articular delivery of drugs. J Pharm Pharmacol 36:431–436

    Article  CAS  PubMed  Google Scholar 

  10. Scott HRE (2011) Intra-articular drug delivery: the challenge to extend drug residence time within the joint. The Veterinary Journal 190:15–21

    Article  CAS  Google Scholar 

  11. Subedi R, Oh S, Chun M-K, Choi H-K (2010) Recent advances in transdermal drug delivery. Arch Pharm Res 33:339–351

    Article  CAS  PubMed  Google Scholar 

  12. Banerjee PS, Ritschel WA (1989) Transdermal permeation of vasopressin. I. Influence of pH, concentration, shaving and surfactant on in vitro permeation. Int J Pharm 49:189–197

    Article  CAS  Google Scholar 

  13. Canga A, Prieto A, Liebana J, Martinez N, Vega M, Vieitez J (2009) The pharmacokinetics and metabolism of ivermectin in domestic animal species. Vet J 179:25–37

    Article  CAS  Google Scholar 

  14. Trepanier LA (2007) Pharmacologic management of feline hyperthyroidism. Vet Clin North Am Small Anim Pract 37:775–788

    Article  PubMed  Google Scholar 

  15. Hoffman SB, Yoder AR, Trepanier LA (2002) Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats. J Vet Pharmacol Ther 25:189–193

    Article  CAS  PubMed  Google Scholar 

  16. MacGregor JM, Rush JE, Rozanski EA, Boothe DM, Belmonte AA, Freeman LM (2008) Comparison of pharmacodynamic variables following oral versus transdermal administration of atenolol to healthy cats. Am J Vet Res 69:39–44

    Article  CAS  PubMed  Google Scholar 

  17. Khor KH, Campbell FE, Charles BG, Norris RLG, Greer RM, Rathbone MJ, Mills PC (2011) Comparative pharmacokinetics and pharmacodynamics of tablet, suspension and paste formulations of atenolol in cats. J Vet Pharmacol Ther. doi:10.1111/j.1365-2885.2011.01342.x:1-10

  18. Kyles A, Papich M, Hardie E (1996) Disposition of transdermally administered fentanyl in dogs. Am J Vet Res 57:715–719

    CAS  PubMed  Google Scholar 

  19. Magnusson B, Walters W, Roberts M (2001) Veterinary drug delivery: potential for skin ­penetration enhancement. Adv Drug Deliv Rev 50:205–227

    Article  CAS  PubMed  Google Scholar 

  20. Sartor LL, Trepanier LA, Kroll MM, Rodan I, Challoner L (2004) Efficacy and safety of transdermal methimazole in the treatment of cats with hyperthyroidism. J Vet Intern Med 18: 651–655

    Article  PubMed  Google Scholar 

  21. Lee DD, Papich MG, Hardie EM (2000) Comparison of pharmacokinetics of fentanyl after intravenous and transdermal administration in cats. Am J Vet Res 61:672–677

    Article  CAS  PubMed  Google Scholar 

  22. Rathbone MJ, Drummond B, Tucker I (1994) The oral cavity as a site for systemic drug delivery. Adv Drug Deliv Rev 13:1–22

    Article  CAS  Google Scholar 

  23. Rathbone MJ, Hadgrath J (1991) Absorption of drugs from the human oral cavity. Int J Pharm 74:9–24

    Article  CAS  Google Scholar 

  24. Abbo L, Ko J, Maxwell L, Galinsky R, Moody D, Johnson B, Fang W (2008) Pharmacokinetics of buprenorphine following intravenous and oral transmucosal administration in dogs. Vet Ther 9:83–93

    PubMed  Google Scholar 

  25. Robertson SA, Lascelles BDX, Taylor PM, Sear JW (2005) PK-PD modeling of buprenorphine in cats: intravenous and oral transmucosal administration1. J Vet Pharmacol Ther 28:453–460

    Article  CAS  PubMed  Google Scholar 

  26. Martinez MN, Papich MG (2009) Factors influencing the gastric residence of dosage forms in dogs. J Pharm Sci 98:844–860

    Article  CAS  PubMed  Google Scholar 

  27. Minami H, McCallum R (1984) The physiology and pathophysiology of gastric emptying in humans. Gastroenterology 86:1592–1610

    Article  CAS  PubMed  Google Scholar 

  28. Davis SS, Hardy JG, Taylor MJ, Whalley DR, Wilson CG (1984) The effect of food on the gastrointestinal transit of pellets and an osmotic device (Osmet). Int J Pharm 21:331–340

    Article  Google Scholar 

  29. Abrahamsson B, Albery T, Eriksson A, Gustafsson I, Sjoberg M (2004) Food effects on tablet disintegration. Eur J Pharm Sci 22:165–172

    Article  CAS  PubMed  Google Scholar 

  30. Kaniwa N, Aoyagi N, Ogata H, Ejima A (1988) Gastric emptying rates of drug preparations. I. Effects of size of dosage forms, food and species on gastric emptying rates. J Pharmacobiodyn 11(8):563–570

    Article  CAS  PubMed  Google Scholar 

  31. Fix JA, Cargill R, Engle K (1993) Controlled gastric emptying III. Gastric residence time of a nondisintegrating geometric shape in human volunteers. Pharm Res 10:1087–1089

    Article  CAS  PubMed  Google Scholar 

  32. Campbell and Rosin (1998) Effect of food on absorption of cefadroxil and cephalexin in dogs. J Vet Pharmacol Ther 21:418–420

    Article  PubMed  Google Scholar 

  33. Tsuji A, Nakashima E, Deguchi NKY, Hamano S, Yamana T (1983) Physicocemical properties of amphoteric B-lactam antibiotics. III Stability, solubility and dissolution behavior of cefatrizine and cefadroxil as a function of pH. Chem Pharm Bull 31:4057–4069

    Article  CAS  Google Scholar 

  34. Sutton S (2009) Role of physiological intestinal water in oral absorption. AAPS J 11:277–285

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Thombre AG, Shah JC, Sagawa K, Caldwell WB (2012) In vitro and in vivo characterization of amorphous, nanocrystalline, and crystalline ziprasidone formulations. Int J Pharm. doi:10.1016/j.ijpharm.2012.02.004:

  36. Sutton SC, Smith PL (2011) Animal model systems suitable for controlled release modeling. In: Wilson CG, Crowleyed PJ (eds) Controlled release in oral drug delivery. Springer, Glasgow

    Google Scholar 

  37. Maddison J (1999) Owner compliance with drug treatment regimens. J Small Anim Pract 40:348

    Article  CAS  PubMed  Google Scholar 

  38. Barter LS, Watson ADJ, Maddison JE (1996) Owner compliance with short term antimicrobial medication in dogs. Aust Vet J 74:277–280

    Article  CAS  PubMed  Google Scholar 

  39. Medlicott NJ, Waldron NA, Foster TP (2004) Sustained release veterinary parenteral products. Adv Drug Deliv Rev 56:1345–1365

    Article  CAS  PubMed  Google Scholar 

  40. Ahmed I, Kasraian K (2002) Pharmaceutical challenges in veterinary product development. Adv Drug Deliv Rev 54:871–882

    Article  CAS  PubMed  Google Scholar 

  41. Mitra A, Wu Y (2010) Use of In Vitro-In Vivo Correlation (IVIVC) to facilitate the development of polymer-based controlled release injectable formulations. Recent Pat Drug Deliv Formul 4:94–104

    Article  CAS  PubMed  Google Scholar 

  42. Vandamme TF, Ellis KJ (2004) Issues and challenges in developing ruminal drug delivery systems. Adv Drug Deliv Rev 56:1415–1436

    Article  CAS  PubMed  Google Scholar 

  43. Prinderre P, Sauzer C, Fuxen C (2011) Advances in gastro retentive drug-delivery systems. Exp Opin Drug Deliv 8:1189–1203

    Article  CAS  Google Scholar 

  44. Rathbone M, Brayden D (2009) Controlled release drug delivery in farmed animals: commercial challenges and academic opportunities. Curr Drug Deliv 6:383–390

    Article  CAS  PubMed  Google Scholar 

  45. Zentner GM, McClelland GA, Sutton SC (1991) Controlled Porosity Solubility- and Resin-Modulated Osmotic Drug Delivery Systems for Release of Diltiazem Hydrochloride. J Controlled Release 16:237–244

    Article  CAS  Google Scholar 

  46. Rapoport JL, Ryland DH, Kriete M (1992) Drug treatment of canine acral lick: an animal model of obsessive-compulsive disorder. Arch Gen Psychiatry 49:517–521

    Article  CAS  PubMed  Google Scholar 

  47. Sutton SC (2004) Companion animal physiology and dosage form performance. Adv Drug Del Rev 56:1383–1398

    Article  CAS  Google Scholar 

  48. Frénais R, Rosenberg D, Burgaud S, Horspool LJI (2009) Clinical efficacy and safety of a once-daily formulation of carbimazole in cats with hyperthyroidism. J Small Anim Pract 50:510–515

    Article  PubMed  Google Scholar 

  49. Longhofer S, Martín-Jiménez T, Soni-Gupta J (2010) Serum concentrations of methimazole in cats after a single oral dose of controlled-release carbimazole or sugar-coated methimazole (thiamazole). Vet Ther 11:E1–E7

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy, University of New England, 716 Stevens Avenue, Portland, ME, 04103, USA

    Steven C. Sutton

Authors
  1. Steven C. Sutton
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven C. Sutton .

Editor information

Editors and Affiliations

  1. Division of Pharmacy, International Medical University, #126 Jalan Jalil Perkasa 19, Bukit Jalil, Kuala Lumpur, 57000, Malaysia

    Michael J. Rathbone

  2. , New Zealand's National School of Pharmac, University of Otago, Dunedin, 9054, New Zealand

    Arlene McDowell

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Controlled Release Society

About this chapter

Cite this chapter

Sutton, S.C. (2013). Biopharmaceutics and Veterinary Drug Delivery. In: Rathbone, M., McDowell, A. (eds) Long Acting Animal Health Drug Products. Advances in Delivery Science and Technology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4439-8_6

Download citation

Publish with us

Policies and ethics

Search

Navigation